NCT00272350 2019-12-05ZD6474 to Treat Advanced Brain Cancer in PatientsNational Institutes of Health Clinical Center (CC)Phase 1 Completed83 enrolled
NCT00995007 2016-03-29A Randomized Phase II Trial of Vandetanib (ZD6474) in Combination With Carboplatin Versus Carboplatin Alone Followed by Vandetanib Alone in Adults With Recurrent High-Grade GliomasNational Institutes of Health Clinical Center (CC)Phase 2 Completed112 enrolled 12 charts